Investors Maintain Nerve Repair Co. Axogen Lied In SEC Docs

By Nathan Hale ( February 25, 2021, 9:59 PM EST) -- Investors urged a Florida federal judge Thursday to let them pursue their claim that nerve repair product manufacturer Axogen lied in stock offering materials, saying they have bolstered proof of the falsehoods and the company's bad faith intentions since the court dismissed a prior version of their complaint....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!